A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
about
Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats.Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation.Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis.Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulationApplications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy.Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.Microbiological characteristics of acute prostatitis after transrectal prostate biopsyThe role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.Efficacy of combination use of Beta-lactamase inhibitor with penicillin and fluoroquinolones for antibiotic prophylaxis in transrectal prostate biopsy.Effects of androgen deprivation on chronic bacterial prostatitis in a rat model.Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation.Population Pharmacokinetics and Penetration into Prostatic, Seminal, and Vaginal Fluid for Ciprofloxacin, Levofloxacin, and Their Combination
P2860
Q34434848-39713220-7470-40BF-A2EF-B970442F5538Q35682214-4E966D49-A713-4B30-9152-D81D0A02011FQ35825795-F37F40BE-D1DC-4109-AC98-1B05CA3BD6E7Q36295483-4CC25465-5B7F-4146-A0D4-5BBC0811A0F3Q36571957-DF0D29D3-F327-40F3-B649-25F5BA090638Q37025462-7D87C0E3-0CD9-4279-8E95-46A579DC40E1Q37037624-A1B4A62E-5870-472A-B0C0-7B50B8A6511BQ37052814-C16BAADF-64BA-43C1-8AD7-86448F1AAEF4Q37152880-F873AA46-C91F-4891-8635-3CE4D1998084Q37190660-9CC122A3-5CF3-4316-9271-F2F82BE95569Q37204197-D9D173DD-A899-488D-9D92-02C7CA140DB8Q37259653-D7EE3675-20B9-4CE6-9083-4D0F48D93FC8Q37642109-4990B746-CBDD-4BED-975B-8E6969FF8747Q38093459-CB93039D-80A5-41C7-BEB1-FCB831EAD040Q38095435-208A4873-277D-4338-9D3E-B15B71F60689Q38680898-D5E6C784-BA40-48D7-B4AB-67F66195AE5CQ39651089-1EA20B22-2C51-42D7-A22C-2179CF40CD0BQ40168017-C675D6AD-400E-48F4-BD4B-E2235CDE0C0BQ40617761-7F99DBF2-A885-4C80-B485-8808B46593A1Q41172930-C76D05CB-7AD4-48E0-8A9E-9C7E1D7C45F6Q41907641-9176564C-C567-496F-8E66-37CC703AFDF7Q42567383-1ADB33AF-FAB0-462B-B693-26F506DB4FB0Q43684626-FC7AE397-2AE9-4C87-B2FA-F041BAB93425Q44571041-A57048E4-D724-4CE0-BD21-1EA585A7FAC2Q53133655-62568CCF-2805-4836-BB1A-E72338DFAC8CQ54337445-34B86ECA-985D-48C6-A72D-58E0B061884EQ57240424-D600D81F-5BA4-4B77-B5AB-A3224B94A518
P2860
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
@en
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
@nl
type
label
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
@en
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
@nl
prefLabel
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
@en
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
@nl
P2093
P2860
P1476
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
@en
P2093
B Weisinger
G L Drusano
L Boccumini
M Oefelein
M Van Guilder
S L Preston
P2860
P304
P356
10.1128/AAC.44.8.2046-2051.2000
P407
P577
2000-08-01T00:00:00Z